Pharmaceutical

Subscribe

PRINCETON, N.J. — Bristol-Myers Squibb Company today announced a donation of $6.9 million to support the HealthWell Foundation, an independent non-profit organization that provides financial assistance to eligible individuals

TRENTON, N.J. — A former Sanofi-Aventis research chemist has pleaded guilty to stealing trade secrets, CourierPostOnline.com reported. Yuan Li, a 29-year-old Chinese national, admitted to accessing, downloading and making

NEW YORK — Bristol-Myers Squibb has agreed to acquire biopharmaceutical company Inhibitex for $26.00 per share, according to a press release. The transaction, with an aggregate purchase price of

WASHINGTON — The Food and Drug Administration has accused Johnson & Johnson’s Animas unit of continuing to sell insulin pumps last year after learning of defects with the devices,

BASEL, Switzerland — Novartis announced Sunday that it is recalling a number of over-the-counter drugs, including certain bottles of Excedrin and Bufferin, due to complaints about chipped and broken

NEW YORK — An appeals court has ordered Pfizer Inc. to pay more than $45 million in damages to two women who claimed they developed breast cancer after taking

ERUSALEM — Teva Pharmaceutical Industries new CEO Jeremy Levin said he plans to shift the company’s focus from generics to branded drugs, The Economic Times reported. Levin, a former

BOSTON — Merck & Co. has agreed to pay $24 million to settle allegations that it overcharged the Massachusetts state Medicaid program, The Boston Globe reported. The settlement represents

SAN DIEGO — According to a study released Wednesday at the American Society of Hematology meeting in San Diego, Pfizer Inc.’s blood-cancer drug Mylotarg, which was pulled from shelves

EAST ST. LOUIS, Mo. — An independent FDA panel has voted 21-5 to require Bayer AG to update warning labels on its popular birth control Yaz to reflect new